Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease-Reference-Cited by-同舟云学术

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease

Published:2011-07 Issue:4 Volume:7 Page:474
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Jack Clifford R.¹,Barkhof Frederik²,Bernstein Matt A.¹,Cantillon Marc³,Cole Patricia E.⁴,DeCarli Charles⁵,Dubois Bruno⁶,Duchesne Simon⁷⁸,Fox Nick C.⁹,Frisoni Giovanni B.¹⁰,Hampel Harald¹¹,Hill Derek L.G.¹²¹³,Johnson Keith¹⁴¹⁵,Mangin Jean‐François¹⁶,Scheltens Philip¹⁷,Schwarz Adam J.¹⁸,Sperling Reisa¹⁹,Suhy Joyce²⁰,Thompson Paul M.²¹,Weiner Michael²²²³,Foster Norman L.²⁴

Affiliation:

1. Department of RadiologyMayo ClinicRochesterMNUSA

2. Department of Radiology and Image Analysis CenterVU University Medical CenterAmsterdamNLUSA

3. Coalition Against Major Diseases, Critical Path InstituteRockvilleMDUSA

4. ImagepaceCincinnatiOHUSA

5. Department of Neurology and Center for NeuroscienceUniversity of California–DavisSacramentoCAUSA

6. Department of NeurologySalpetriere Hospital, Pierre and Marie Curie UniversityParisFrance

7. Departement de RadiologieCentre de Recherche UniversitÉ Laval Robert‐GiffardQuebecQCCanada

8. Department of RadiologyUniversitÉ LavalQuÉbecQCCanada

9. Dementia Research Centre, UCL Institute of NeurologyLondonUnited Kingdom

10. Laboratory of Epidemiology and Neuroimaging, IRCCS San Giovanni di Dio‐FBFBresciaItaly

11. Department of PsychiatryPsychosomatic Medicine and Psychotherapy, Goethe UniversityFrankfurtGermany

12. Department of Medical Physics and BioengineeringCentre for Medical Image Computing, University CollegeLondonUnited Kingdom

13. IXICO Ltd, The London Bioscience Innovation CentreLondonUnited Kingdom

14. Department of NeurologyCenter for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical SchoolBostonMAUSA

15. Division of Molecular ImagingMassachusetts General Hospital, Harvard Medical SchoolBostonMAUSA

16. Neurospin, I2BM, CEASaclayFrance

17. Department of Neurology and Alzheimer CenterVU University Medical CenterAmsterdamNLUSA

18. Translational Medicine, Eli Lilly and CompanyIndianapolisINUSA

19. Department of NeurologyBrigham and Women's Hospital, Harvard Medical SchoolBostonMAUSA

20. Division of NeurologySynarc Inc.San FranciscoCAUSA

21. Department of NeurologyLaboratory of Neuro Imaging, UCLA School of MedicineLos AngelesCAUSA

22. Department of Veterans AffairsCenter for Imaging of Neurodegenerative Disease, VA Medical CenterSan FranciscoCAUSA

23. Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoCAUSA

24. Department of NeurologyCenter for Alzheimer's Care, Imaging and Research, University of UtahSalt Lake CityUTUSA

Funder

Pfizer

National Institute on Aging

Medical Research Council

National Institutes of Health

National Institute for Health Research

Engineering and Physical Sciences Research Council

Alzheimer's Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2011.04.007

Reference96 articles.

1. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

2. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

3. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

4. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

5. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mediation Analysis with Multiple Exposures and Multiple Mediators;Statistics in Medicine;2024-09-09

2. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-09-05

3. Different associations between body mass index and Alzheimer’s markers depending on metabolic health;Alzheimer's Research & Therapy;2024-08-29

4. Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population;Frontiers in Aging Neuroscience;2024-07-23

5. Investigating the Impact of Intracerebroventricular Streptozotocin on Female Rats with and without Ovaries: Implications for Alzheimer’s Disease;Neurochemical Research;2024-07-10